The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3148.2008.00846.x/fullpdf
Reference25 articles.
1. Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials
2. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial
3. Factor VIIa replacement therapy in factor VII deficiency1
4. Abstract
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Massive Blood Loss in Neurosurgery;Transfusion Practice in Clinical Neurosciences;2022
2. Anesthesia for Patients with Extensive Trauma;Anesthesiology Clinics;2020-03
3. Inferior Vena Cava Volume Is an Independent Predictor of Massive Transfusion in Patients With Trauma;Journal of Intensive Care Medicine;2019-12-13
4. Rational and Timely Use of Coagulation Factor Concentrates in Massive Bleeding Without Point-of-Care Coagulation Monitoring;Annual Update in Intensive Care and Emergency Medicine;2015
5. Blood conservation in cardiac surgery: Guidelines and controversies;Transfusion and Apheresis Science;2014-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3